RENEE MATHIS: Open Payments
NPI 1952919102 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,334 in 81 payments from 12 companies in 2025. Trend: 2023 $1,667 · 2024 $1,814 · 2025 $1,334
Food & beverage: $1,334
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 20 | $334 |
| Axsome Therapeutics, Inc. | 24 | $233 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $215 |
| Alkermes, Inc. | 8 | $181 |
| Janssen Pharmaceuticals, Inc | 6 | $132 |
| Vanda Pharmaceuticals Inc. | 4 | $66 |
| Supernus Pharmaceuticals, Inc. | 3 | $59 |
| ABBVIE INC. | 1 | $30 |
| Lundbeck LLC | 1 | $30 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
Products named: REXULTI, Auvelity, CAPLYTA, ARISTADA, SPRAVATO, Qelbree, FANAPT, HETLIOZ.
Industry payments across TN — which companies pay providers there.
